Medicare Enrolled

Dr. Sushanth Kakarla

Student in an Organized Health Care Education/Training Program · San Antonio, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4502 MEDICAL DR, San Antonio, TX 78229
2103583000
In practice since 2016 (9 years)
NPI: 1710338173 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kakarla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kakarla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kakarla

Dr. Sushanth Kakarla is a student in an organized health care education/training program specialist in San Antonio, TX, with 9 years of NPI registration. Based on federal Medicare data, Dr. Kakarla performed 487 Medicare services across 309 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kakarla received a total of $4,500 from 54 pharmaceutical and/or device companies across 175 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kakarla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice ▲ Top 39% volume in TX $4,500 industry payments

Medicare Practice Summary

Medicare Utilization ↗
487
Medicare services
Top 39% in TX for student in an organized health care education/training program
309
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~54 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min) 196 $70 $127
Office visit, established patient, complex (40-54 min) 147 $107 $178
New patient office visit, complex (60-74 min) 80 $133 $238
Hospital follow-up visit, moderate complexity 26 $60 $207
Office visit, established patient (20-29 min) 22 $48 $90
Initial hospital admission, moderate complexity 16 $96 $395
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,500
Total received (2020-2024)
Avg $900/year across 5 years
Top 8% in TX for student in an organized health care education/training program
54
Companies
175
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,166 (92.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$335 (7.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,960
2023
$1,434
2022
$996
2021
$77
2020
$34

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$507
AstraZeneca Pharmaceuticals LP
$468
GENZYME CORPORATION
$262
Novartis Pharmaceuticals Corporation
$223
Amgen Inc.
$182
Seagen Inc.
$181
Merck Sharp & Dohme LLC
$177
Blueprint Medicines Corporation
$176
PFIZER INC.
$174
Celgene Corporation
$156
Daiichi Sankyo Inc.
$131
SOBI, INC
$118
Janssen Biotech, Inc.
$102
Janssen Scientific Affairs, LLC
$88
Mirati Therapeutics, Inc.
$88
Eisai Inc.
$84
ABBVIE INC.
$82
Myriad Genetic Laboratories, Inc.
$75
Rigel Pharmaceuticals, Inc.
$71
Gilead Sciences, Inc.
$61
Regeneron Healthcare Solutions, Inc.
$60
TerSera Therapeutics LLC
$57
Exelixis Inc.
$55
Stemline Therapeutics Inc.
$55
Aveo Pharmaceuticals, Inc.
$55
GlaxoSmithKline, LLC.
$55
Sumitomo Pharma America, Inc.
$48
Taiho Oncology, Inc.
$47
PharmaEssentia USA Corporation
$45
Kite Pharma, Inc.
$38
Coherus Biosciences Inc.
$36
Lilly USA, LLC
$36
Genentech USA, Inc.
$34
Takeda Pharmaceuticals U.S.A., Inc.
$33
Karyopharm Therapeutics Inc.
$32
Jazz Pharmaceuticals Inc.
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
ARRAY BIOPHARMA INC
$28
Ipsen Biopharmaceuticals, Inc
$27
EMD Serono, Inc.
$24
Adaptive Biotechnologies Corporation
$23
MorphoSys, US Inc.
$22
PROGENICS PHARMACEUTICALS, INC.
$22
Apellis Pharmaceuticals, Inc.
$22
Incyte Corporation
$21
Alexion Pharmaceuticals, Inc.
$20
PUMA BIOTECHNOLOGY, INC.
$20
Foundation Medicine, Inc.
$18
Alnylam Pharmaceuticals Inc.
$17
Progenics Pharmaceuticals, Inc.
$17
Puma Biotechnology, Inc.
$17
Spectrum Pharmaceuticals Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Pharmacyclics LLC, an AbbVie Company
$16
Top 3 companies account for 27.5% of total payments
Associated products mentioned in payments ›
ALUNBRIG · AYVAKIT · BESREMI · BLENREP · BOSULIF · BRAFTOVI · CABOMETYX · CARVYKTI · CEREZYME · CREON · Cabometyx · Columvi · DARZALEX · Doptelet · ENHERTU · ENJAYMO · EVUSHELD · Empaveli · Enhertu · FOTIVDA · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · GILOTRIF · IMBRUVICA · INJECTAFER · INLYTA · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MYRISK · NERLYNX · Nplate · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXLUMO · Onivyde · Orserdu · PADCEV · PLUVICTO · PRECISETUMOR · PROMACTA · PYLARIFY · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · SARCLISA · SCEMBLIX · Stivarga · TAGRISSO · TECVAYLI · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · XALKORI · XGEVA · XPOVIO · Xermelo · Yescarta · ZEJULA · ZEPZELCA · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for student in an organized health care education/training program in TX.

Equivalent to $924 per 100 Medicare services performed
Looking for a student in an organized health care education/training program specialist in San Antonio?
Compare student in an organized health care education/training programs in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse student in an organized health care education/training programs nearby

Geographic Context

Student in an organized health care education/training programs within 10 mi
2,327
Per 100K population
114.2
County median income
$70,571
Nearest hospital
UNIVERSITY HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Kakarla is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of TX peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Kakarla experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Kakarla performed 196 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kakarla receive payments from pharmaceutical companies?
Yes. Dr. Kakarla received a total of $4,500 from 54 companies across 175 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kakarla's costs compare to other student in an organized health care education/training programs in San Antonio?
Dr. Kakarla's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kakarla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →